A case of Stevens-Johnson syndrome caused by acetazolamide

Korean Journal of Dermatology

Volumn 41, Issue 2, 2003, Pages 248-250

  Ha, Ji Hyun ^a   Song, Ji Yeon ^a   Kim, Hyung Ok ^a   Kim, Jeong Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Acetazolamide; HLA tying; Stevens Johnson sydrome

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; HLA ANTIGEN; HLA B ANTIGEN; HLA B59 ANTIGEN; METHAZOLAMIDE; PREDNISOLONE; STEROID; SULFONAMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; EYE DISEASE; GLAUCOMA; HLA TYPING; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; RISK FACTOR; SKIN BIOPSY; STEVENS JOHNSON SYNDROME;

EID: 0037960277     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Mondino BJ, Brown SI, Rabin BS. HLA antigens in Stevens-Johnson syndrome with ocular Involvement. Arch Ophthalmol 1982;100:1453-1454
2. Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptability to toxic epidermal necrolysis. Arch Dermatol 1987;123:1171-1173
3. Shiraoki S, Fumie K, Yasuyuki S, Satoru J. Stevens-Johnson syndrome methazolamide treatment. Arch Ophthalmol 1997;115:550-553
4. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tshuji K, Aizawa M, Sasazuki T, eds. HLA 1991. New York, NY:Oxford University Press Inc;1991:1065-1220